_id
690dab44ccc777a4e85d0913
Ticker
AGNPF
Name
Algernon Pharmaceuticals Inc
Exchange
OTCQB
Address
601 West Broadway, Vancouver, BC, Canada, V5Z 4C2
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.algernonhealth.com
Description
Algernon Health Inc. operates as a clinical stage pharmaceutical development company in Canada and Australia. The company focuses on developing the therapeutic drugs in the areas of non-alcoholic steatohepatitis, liver disease, chronic kidney disease, and stroke program. Its pipeline includes repirinast for the treatment of chronic kidney disease; and N,N-Dimethyltryptamine for the treatment of strokes and traumatic brain injuries. The company was formerly known as Algernon Pharmaceuticals Inc. and changed its name to Algernon Health Inc. in October 2025. Algernon Health Inc. was incorporated in 2015 and is headquartered in Vancouver, Canada.
Last Close
0.04
Volume
136
Current Price
0.04
Change
-0.0025
Last Updated
2026-01-20T14:55:07.907Z
Image
data:image/webp;base64,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
Ipo Date
-
Market Cap
1821508
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2025-08-31
Revenue
0
Cost Of Revenue
-
Gross Profit
-
Operating Expenses
380733
Operating Income
-380733
Interest Expense
-
Pretax Income
-380500
Net Income
-380500
Eps
-0.011107472193589141
Dividends Per Share
-
Shares Outstanding
44820685
Income Tax Expense
-
EBITDA
-
Operating Margin
-
Total Other Income Expense Net
-
Cash
176501
Short Term Investments
-
Receivables
-
Inventories
-
Total Current Assets
554472
Property Plant Equipment
-
Total Assets
4877474
Payables
-
Short Term Debt
-
Long Term Debt
-
Total Liabilities
2182240
Equity
2695234
Bs_currency_symbol
CAD
Depreciation
34484
Change In Working Capital
-141330
Cash From Operations
-489057
Capital Expenditures
9747
Cash From Investing
-
Cash From Financing
587100
Net Change In Cash
88325
Cf_currency_symbol
CAD
PE
-
PB
0.5083969555148088
ROE
-14.117512616715283
ROA
-7.801169211768223
FCF
-498804
Fcf Percent
-
Piotroski FScore
0
Health Score
37
Deep Value Investing Score
4
Defensive Investing Score
4.5
Dividend Investing Score
1.5
Economic Moat Investing Score
3.8
Garp Investing Score
1.5
Growth Investing Score
0.5
Momentum Investing Score
2.5
Net Net Investing Score
2.5
Quality Investing Score
2.5
Value Investing Score
5
Quarters > 0 > quarter
2025-08-31
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
-
Quarters > 0 > income Statement > operating Expenses
380733
Quarters > 0 > income Statement > operating Income
-380733
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-380500
Quarters > 0 > income Statement > net Income
-380500
Quarters > 0 > income Statement > eps
-0.011107472193589141
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
34256219
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
-
Quarters > 0 > income Statement > currency_symbol
CAD
Quarters > 0 > balance Sheet > cash
176501
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
554472
Quarters > 0 > balance Sheet > property Plant Equipment
-
Quarters > 0 > balance Sheet > total Assets
4877474
Quarters > 0 > balance Sheet > payables
-
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
2182240
Quarters > 0 > balance Sheet > equity
2695234
Quarters > 0 > balance Sheet > currency_symbol
CAD
Quarters > 0 > cash Flow > net Income
-380500
Quarters > 0 > cash Flow > depreciation
34484
Quarters > 0 > cash Flow > change In Working Capital
-141330
Quarters > 0 > cash Flow > cash From Operations
-489057
Quarters > 0 > cash Flow > capital Expenditures
9747
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
587100
Quarters > 0 > cash Flow > net Change In Cash
88325
Quarters > 0 > cash Flow > currency_symbol
CAD
Quarters > 0 > ratios > PE
-0.011107472193589141
Quarters > 0 > ratios > PB
0.5083969555148088
Quarters > 0 > ratios > ROE
-14.117512616715283
Quarters > 0 > ratios > ROA
-7.801169211768223
Quarters > 0 > ratios > FCF
-498804
Quarters > 0 > ratios > Piotroski FScore
0
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
37
Quarters > 1 > quarter
2025-05-31
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
-
Quarters > 1 > income Statement > gross Profit
-
Quarters > 1 > income Statement > operating Expenses
583211
Quarters > 1 > income Statement > operating Income
-583211
Quarters > 1 > income Statement > interest Expense
14
Quarters > 1 > income Statement > pretax Income
-583225
Quarters > 1 > income Statement > net Income
-583225
Quarters > 1 > income Statement > eps
-0.017025375742722802
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
34256219
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
-
Quarters > 1 > income Statement > currency_symbol
CAD
Quarters > 1 > balance Sheet > cash
88176
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
14936
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
233880
Quarters > 1 > balance Sheet > property Plant Equipment
-
Quarters > 1 > balance Sheet > total Assets
4881105
Quarters > 1 > balance Sheet > payables
2066490
Quarters > 1 > balance Sheet > short Term Debt
-
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
3139546
Quarters > 1 > balance Sheet > equity
1741559
Quarters > 1 > balance Sheet > currency_symbol
CAD
Quarters > 1 > cash Flow > net Income
-583225
Quarters > 1 > cash Flow > depreciation
8664
Quarters > 1 > cash Flow > change In Working Capital
200471
Quarters > 1 > cash Flow > cash From Operations
-174524
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
0
Quarters > 1 > cash Flow > net Change In Cash
-4005
Quarters > 1 > cash Flow > currency_symbol
CAD
Quarters > 1 > ratios > PE
-0.017025375742722802
Quarters > 1 > ratios > PB
0.7867943377169536
Quarters > 1 > ratios > ROE
-33.488673079694685
Quarters > 1 > ratios > ROA
-11.948626386852977
Quarters > 1 > ratios > FCF
-174524
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
32
Quarters > 2 > quarter
2025-02-28
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
-
Quarters > 2 > income Statement > gross Profit
-
Quarters > 2 > income Statement > operating Expenses
372527
Quarters > 2 > income Statement > operating Income
-372527
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-372267
Quarters > 2 > income Statement > net Income
-372267
Quarters > 2 > income Statement > eps
-0.013635544991599092
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
27301219
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
-
Quarters > 2 > income Statement > currency_symbol
CAD
Quarters > 2 > balance Sheet > cash
92181
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
19548
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
148393
Quarters > 2 > balance Sheet > property Plant Equipment
-
Quarters > 2 > balance Sheet > total Assets
3378024
Quarters > 2 > balance Sheet > payables
1880167
Quarters > 2 > balance Sheet > short Term Debt
-
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
1962243
Quarters > 2 > balance Sheet > equity
1415781
Quarters > 2 > balance Sheet > currency_symbol
CAD
Quarters > 2 > cash Flow > net Income
-372267
Quarters > 2 > cash Flow > depreciation
5984
Quarters > 2 > cash Flow > change In Working Capital
84904
Quarters > 2 > cash Flow > cash From Operations
-249421
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
-
Quarters > 2 > cash Flow > cash From Financing
0
Quarters > 2 > cash Flow > net Change In Cash
-265742
Quarters > 2 > cash Flow > currency_symbol
CAD
Quarters > 2 > ratios > PE
-0.013635544991599092
Quarters > 2 > ratios > PB
0.771340171961624
Quarters > 2 > ratios > ROE
-26.294109046526266
Quarters > 2 > ratios > ROA
-11.020259181107061
Quarters > 2 > ratios > FCF
-249421
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
32
Quarters > 3 > quarter
2024-11-30
Quarters > 3 > income Statement > revenue
0
Quarters > 3 > income Statement > cost Of Revenue
-
Quarters > 3 > income Statement > gross Profit
-
Quarters > 3 > income Statement > operating Expenses
381323
Quarters > 3 > income Statement > operating Income
-381323
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-381063
Quarters > 3 > income Statement > net Income
-381063
Quarters > 3 > income Statement > eps
-0.013957728407658281
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
27301219
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-
Quarters > 3 > income Statement > operating Margin
-
Quarters > 3 > income Statement > total Other Income Expense Net
-
Quarters > 3 > income Statement > currency_symbol
CAD
Quarters > 3 > balance Sheet > cash
357923
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
13426
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
425823
Quarters > 3 > balance Sheet > property Plant Equipment
-
Quarters > 3 > balance Sheet > total Assets
3654510
Quarters > 3 > balance Sheet > payables
1838939
Quarters > 3 > balance Sheet > short Term Debt
-
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
1866756
Quarters > 3 > balance Sheet > equity
1787754
Quarters > 3 > balance Sheet > currency_symbol
CAD
Quarters > 3 > cash Flow > net Income
-381063
Quarters > 3 > cash Flow > depreciation
5560
Quarters > 3 > cash Flow > change In Working Capital
113086
Quarters > 3 > cash Flow > cash From Operations
-244039
Quarters > 3 > cash Flow > capital Expenditures
0
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
208
Quarters > 3 > cash Flow > net Change In Cash
-238275
Quarters > 3 > cash Flow > currency_symbol
CAD
Quarters > 3 > ratios > PE
-0.013957728407658281
Quarters > 3 > ratios > PB
0.610849568788547
Quarters > 3 > ratios > ROE
-21.315180947714282
Quarters > 3 > ratios > ROA
-10.427198174310647
Quarters > 3 > ratios > FCF
-244039
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
32
Annuals > 0 > quarter
2025-08-31
Annuals > 0 > income Statement > revenue
0
Annuals > 0 > income Statement > cost Of Revenue
-
Annuals > 0 > income Statement > gross Profit
-
Annuals > 0 > income Statement > operating Expenses
1717794
Annuals > 0 > income Statement > operating Income
-1717794
Annuals > 0 > income Statement > interest Expense
-
Annuals > 0 > income Statement > pretax Income
-1717055
Annuals > 0 > income Statement > net Income
-1717055
Annuals > 0 > income Statement > eps
-0.05012389137283364
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
34256219
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
-
Annuals > 0 > income Statement > currency_symbol
CAD
Annuals > 0 > balance Sheet > cash
176501
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
-
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
554472
Annuals > 0 > balance Sheet > property Plant Equipment
-
Annuals > 0 > balance Sheet > total Assets
4877474
Annuals > 0 > balance Sheet > payables
-
Annuals > 0 > balance Sheet > short Term Debt
-
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
2182240
Annuals > 0 > balance Sheet > equity
2695234
Annuals > 0 > balance Sheet > currency_symbol
CAD
Annuals > 0 > cash Flow > net Income
-1717055
Annuals > 0 > cash Flow > depreciation
54692
Annuals > 0 > cash Flow > change In Working Capital
257131
Annuals > 0 > cash Flow > cash From Operations
-1157041
Annuals > 0 > cash Flow > capital Expenditures
24966
Annuals > 0 > cash Flow > cash From Investing
-
Annuals > 0 > cash Flow > cash From Financing
587308
Annuals > 0 > cash Flow > net Change In Cash
-419697
Annuals > 0 > cash Flow > currency_symbol
CAD
Annuals > 0 > ratios > PE
-0.05012389137283364
Annuals > 0 > ratios > PB
0.5083969555148088
Annuals > 0 > ratios > ROE
-63.707084431259034
Annuals > 0 > ratios > ROA
-35.20377556087434
Annuals > 0 > ratios > FCF
-1182007
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
29
Annuals > 1 > quarter
2024-08-31
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
-
Annuals > 1 > income Statement > gross Profit
-
Annuals > 1 > income Statement > operating Expenses
2412042
Annuals > 1 > income Statement > operating Income
-2412042
Annuals > 1 > income Statement > interest Expense
-
Annuals > 1 > income Statement > pretax Income
-502982
Annuals > 1 > income Statement > net Income
-502982
Annuals > 1 > income Statement > eps
-0.018423696373357883
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
27300819
Annuals > 1 > income Statement > income Tax Expense
-
Annuals > 1 > income Statement > EBITDA
-
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
1907692
Annuals > 1 > income Statement > currency_symbol
CAD
Annuals > 1 > balance Sheet > cash
596198
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
-
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
738763
Annuals > 1 > balance Sheet > property Plant Equipment
-
Annuals > 1 > balance Sheet > total Assets
3944040
Annuals > 1 > balance Sheet > payables
-
Annuals > 1 > balance Sheet > short Term Debt
-
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
1775447
Annuals > 1 > balance Sheet > equity
2168593
Annuals > 1 > balance Sheet > currency_symbol
CAD
Annuals > 1 > cash Flow > net Income
-502982
Annuals > 1 > cash Flow > depreciation
26562
Annuals > 1 > cash Flow > change In Working Capital
-616196
Annuals > 1 > cash Flow > cash From Operations
-2709577
Annuals > 1 > cash Flow > capital Expenditures
84025
Annuals > 1 > cash Flow > cash From Investing
-
Annuals > 1 > cash Flow > cash From Financing
901089
Annuals > 1 > cash Flow > net Change In Cash
471113
Annuals > 1 > cash Flow > currency_symbol
CAD
Annuals > 1 > ratios > PE
-0.018423696373357883
Annuals > 1 > ratios > PB
0.5035674098367006
Annuals > 1 > ratios > ROE
-23.193932655874107
Annuals > 1 > ratios > ROA
-12.7529639658827
Annuals > 1 > ratios > FCF
-2793602
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
29
Annuals > 2 > quarter
2023-08-31
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
-
Annuals > 2 > income Statement > gross Profit
-
Annuals > 2 > income Statement > operating Expenses
5241991
Annuals > 2 > income Statement > operating Income
-5241991
Annuals > 2 > income Statement > interest Expense
-
Annuals > 2 > income Statement > pretax Income
-6781200
Annuals > 2 > income Statement > net Income
-6781200
Annuals > 2 > income Statement > eps
-0.42984942022116596
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
15775757
Annuals > 2 > income Statement > income Tax Expense
-
Annuals > 2 > income Statement > EBITDA
-
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
-1541306
Annuals > 2 > income Statement > currency_symbol
CAD
Annuals > 2 > balance Sheet > cash
125085
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
-
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
339829
Annuals > 2 > balance Sheet > property Plant Equipment
-
Annuals > 2 > balance Sheet > total Assets
4193699
Annuals > 2 > balance Sheet > payables
-
Annuals > 2 > balance Sheet > short Term Debt
-
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
2719760
Annuals > 2 > balance Sheet > equity
1473939
Annuals > 2 > balance Sheet > currency_symbol
CAD
Annuals > 2 > cash Flow > net Income
-6781200
Annuals > 2 > cash Flow > depreciation
50398
Annuals > 2 > cash Flow > change In Working Capital
1265717
Annuals > 2 > cash Flow > cash From Operations
-2553008
Annuals > 2 > cash Flow > capital Expenditures
59500
Annuals > 2 > cash Flow > cash From Investing
-
Annuals > 2 > cash Flow > cash From Financing
1328909
Annuals > 2 > cash Flow > net Change In Cash
-1283424
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-0.42984942022116596
Annuals > 2 > ratios > PB
0.4281250987998825
Annuals > 2 > ratios > ROE
-460.07331375314715
Annuals > 2 > ratios > ROA
-161.69973095350906
Annuals > 2 > ratios > FCF
-2612508
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
23
Annuals > 3 > quarter
2022-08-31
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
-
Annuals > 3 > income Statement > gross Profit
-
Annuals > 3 > income Statement > operating Expenses
6056434
Annuals > 3 > income Statement > operating Income
-6056434
Annuals > 3 > income Statement > interest Expense
-
Annuals > 3 > income Statement > pretax Income
-6054356
Annuals > 3 > income Statement > net Income
-6054356
Annuals > 3 > income Statement > eps
-2.567706228251166
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
2357885
Annuals > 3 > income Statement > income Tax Expense
-
Annuals > 3 > income Statement > EBITDA
-6021498
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
-36479
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
1408509
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
665529
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
2827098
Annuals > 3 > balance Sheet > property Plant Equipment
-
Annuals > 3 > balance Sheet > total Assets
8140757
Annuals > 3 > balance Sheet > payables
2242067
Annuals > 3 > balance Sheet > short Term Debt
-
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
2516099
Annuals > 3 > balance Sheet > equity
5624658
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-6054356
Annuals > 3 > cash Flow > depreciation
34936
Annuals > 3 > cash Flow > change In Working Capital
2584486
Annuals > 3 > cash Flow > cash From Operations
-2912741
Annuals > 3 > cash Flow > capital Expenditures
144608
Annuals > 3 > cash Flow > cash From Investing
-144608
Annuals > 3 > cash Flow > cash From Financing
2055123
Annuals > 3 > cash Flow > net Change In Cash
-1002654
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-2.567706228251166
Annuals > 3 > ratios > PB
0.01676820172888734
Annuals > 3 > ratios > ROE
-107.63954003958996
Annuals > 3 > ratios > ROA
-74.37092152486557
Annuals > 3 > ratios > FCF
-3057349
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
33
Valuation > metrics > PE
-0.011107472193589141
Valuation > metrics > PB
0.5083969555148088
Valuation > final Score
70
Valuation > verdict
49.2% Undervalued
Profitability > metrics > ROE
-14.117512616715283
Profitability > metrics > ROA
-68.62384394523077
Profitability > final Score
15
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.8096662479027795
Risk > final Score
68
Risk > verdict
High
Liquidity > final Score
50
Liquidity > verdict
Weak
Prev Valuations > 0
70
Prev Valuations > 1
70
Prev Valuations > 2
70
Prev Profitabilities > 0
15
Prev Profitabilities > 1
15
Prev Profitabilities > 2
15
Prev Risks > 0
-166602
Prev Risks > 1
50
Prev Risks > 2
50
Prev Liquidities > 0
16
Prev Liquidities > 1
14
Prev Liquidities > 2
22
Updated At
2026-01-20T21:21:02.072Z
Earnings History > 0 > period
2025-05-31
Earnings History > 0 > report Date
2025-05-31
Earnings History > 0 > date
2025-05-31
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-0.0143
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-02-28
Earnings History > 1 > report Date
2025-02-28
Earnings History > 1 > date
2025-02-28
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.0095
Earnings History > 1 > eps Estimate
-
Earnings History > 1 > eps Difference
0
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2024-11-30
Earnings History > 2 > report Date
2024-11-30
Earnings History > 2 > date
2024-11-30
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.0101
Earnings History > 2 > eps Estimate
-
Earnings History > 2 > eps Difference
0
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2024-08-31
Earnings History > 3 > report Date
2024-08-31
Earnings History > 3 > date
2024-08-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
-0.0113
Earnings History > 3 > eps Estimate
-
Earnings History > 3 > eps Difference
0
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2024-05-31
Earnings History > 4 > report Date
2024-07-29
Earnings History > 4 > date
2024-05-31
Earnings History > 4 > before After Market
AfterMarket
Earnings History > 4 > currency
CAD
Earnings History > 4 > eps Actual
0.0486
Earnings History > 4 > eps Estimate
-
Earnings History > 4 > eps Difference
0
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2024-02-29
Earnings History > 5 > report Date
2024-04-16
Earnings History > 5 > date
2024-02-29
Earnings History > 5 > before After Market
AfterMarket
Earnings History > 5 > currency
CAD
Earnings History > 5 > eps Actual
-0.0388
Earnings History > 5 > eps Estimate
-
Earnings History > 5 > eps Difference
0
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2023-11-30
Earnings History > 6 > report Date
2023-12-29
Earnings History > 6 > date
2023-11-30
Earnings History > 6 > before After Market
AfterMarket
Earnings History > 6 > currency
CAD
Earnings History > 6 > eps Actual
-0.0242
Earnings History > 6 > eps Estimate
-
Earnings History > 6 > eps Difference
0
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2023-08-31
Earnings History > 7 > report Date
2023-08-31
Earnings History > 7 > date
2023-08-31
Earnings History > 7 > before After Market
-
Earnings History > 7 > currency
CAD
Earnings History > 7 > eps Actual
-0.1201
Earnings History > 7 > eps Estimate
-
Earnings History > 7 > eps Difference
0
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2023-05-31
Earnings History > 8 > report Date
2023-05-31
Earnings History > 8 > date
2023-05-31
Earnings History > 8 > before After Market
-
Earnings History > 8 > currency
CAD
Earnings History > 8 > eps Actual
-0.0748
Earnings History > 8 > eps Estimate
-
Earnings History > 8 > eps Difference
0
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2023-02-28
Earnings History > 9 > report Date
2023-02-28
Earnings History > 9 > date
2023-02-28
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
CAD
Earnings History > 9 > eps Actual
-0.0241
Earnings History > 9 > eps Estimate
-
Earnings History > 9 > eps Difference
0
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2022-11-30
Earnings History > 10 > report Date
2023-01-30
Earnings History > 10 > date
2022-11-30
Earnings History > 10 > before After Market
AfterMarket
Earnings History > 10 > currency
CAD
Earnings History > 10 > eps Actual
-0.2
Earnings History > 10 > eps Estimate
-0.16
Earnings History > 10 > eps Difference
-0.04
Earnings History > 10 > surprise Percent
-25
Earnings History > 11 > period
2022-08-31
Earnings History > 11 > report Date
2022-11-25
Earnings History > 11 > date
2022-08-31
Earnings History > 11 > before After Market
AfterMarket
Earnings History > 11 > currency
CAD
Earnings History > 11 > eps Actual
0.3
Earnings History > 11 > eps Estimate
-0.17
Earnings History > 11 > eps Difference
0.47
Earnings History > 11 > surprise Percent
276.4706
Earnings History > 12 > period
2022-05-31
Earnings History > 12 > report Date
2022-07-29
Earnings History > 12 > date
2022-05-31
Earnings History > 12 > before After Market
BeforeMarket
Earnings History > 12 > currency
CAD
Earnings History > 12 > eps Actual
0.12
Earnings History > 12 > eps Estimate
-0.23
Earnings History > 12 > eps Difference
0.35
Earnings History > 12 > surprise Percent
152.1739
Earnings History > 13 > period
2022-02-28
Earnings History > 13 > report Date
2022-04-26
Earnings History > 13 > date
2022-02-28
Earnings History > 13 > before After Market
AfterMarket
Earnings History > 13 > currency
CAD
Earnings History > 13 > eps Actual
-0.8622
Earnings History > 13 > eps Estimate
-
Earnings History > 13 > eps Difference
0
Earnings History > 13 > surprise Percent
-
Earnings History > 14 > period
2021-11-30
Earnings History > 14 > report Date
2022-01-27
Earnings History > 14 > date
2021-11-30
Earnings History > 14 > before After Market
AfterMarket
Earnings History > 14 > currency
CAD
Earnings History > 14 > eps Actual
-0.5706
Earnings History > 14 > eps Estimate
-
Earnings History > 14 > eps Difference
0
Earnings History > 14 > surprise Percent
-
Earnings History > 15 > period
2021-08-31
Earnings History > 15 > report Date
2021-11-25
Earnings History > 15 > date
2021-08-31
Earnings History > 15 > before After Market
AfterMarket
Earnings History > 15 > currency
CAD
Earnings History > 15 > eps Actual
-0.08
Earnings History > 15 > eps Estimate
-0.75
Earnings History > 15 > eps Difference
0.67
Earnings History > 15 > surprise Percent
89.3333
Earnings History > 16 > period
2021-05-31
Earnings History > 16 > report Date
2021-07-30
Earnings History > 16 > date
2021-05-31
Earnings History > 16 > before After Market
AfterMarket
Earnings History > 16 > currency
CAD
Earnings History > 16 > eps Actual
-0.25
Earnings History > 16 > eps Estimate
-0.5
Earnings History > 16 > eps Difference
0.25
Earnings History > 16 > surprise Percent
50
Earnings History > 17 > period
2021-02-28
Earnings History > 17 > report Date
2021-04-29
Earnings History > 17 > date
2021-02-28
Earnings History > 17 > before After Market
AfterMarket
Earnings History > 17 > currency
CAD
Earnings History > 17 > eps Actual
-0.5
Earnings History > 17 > eps Estimate
-0.75
Earnings History > 17 > eps Difference
0.25
Earnings History > 17 > surprise Percent
33.3333
Earnings History > 18 > period
2020-11-30
Earnings History > 18 > report Date
2021-01-29
Earnings History > 18 > date
2020-11-30
Earnings History > 18 > before After Market
BeforeMarket
Earnings History > 18 > currency
CAD
Earnings History > 18 > eps Actual
-2
Earnings History > 18 > eps Estimate
-3
Earnings History > 18 > eps Difference
1
Earnings History > 18 > surprise Percent
33.3333
Earnings History > 19 > period
2020-08-31
Earnings History > 19 > report Date
2020-08-31
Earnings History > 19 > date
2020-08-31
Earnings History > 19 > before After Market
-
Earnings History > 19 > currency
CAD
Earnings History > 19 > eps Actual
-0.3963
Earnings History > 19 > eps Estimate
-
Earnings History > 19 > eps Difference
0
Earnings History > 19 > surprise Percent
-
Earnings History > 20 > period
2020-05-31
Earnings History > 20 > report Date
2020-07-29
Earnings History > 20 > date
2020-05-31
Earnings History > 20 > before After Market
AfterMarket
Earnings History > 20 > currency
CAD
Earnings History > 20 > eps Actual
-0.0316
Earnings History > 20 > eps Estimate
-
Earnings History > 20 > eps Difference
0
Earnings History > 20 > surprise Percent
-
Earnings History > 21 > period
2020-02-29
Earnings History > 21 > report Date
2020-04-28
Earnings History > 21 > date
2020-02-29
Earnings History > 21 > before After Market
AfterMarket
Earnings History > 21 > currency
CAD
Earnings History > 21 > eps Actual
-0.0081
Earnings History > 21 > eps Estimate
-
Earnings History > 21 > eps Difference
0
Earnings History > 21 > surprise Percent
-
Earnings History > 22 > period
2019-11-30
Earnings History > 22 > report Date
2020-01-28
Earnings History > 22 > date
2019-11-30
Earnings History > 22 > before After Market
AfterMarket
Earnings History > 22 > currency
CAD
Earnings History > 22 > eps Actual
-0.0023
Earnings History > 22 > eps Estimate
-
Earnings History > 22 > eps Difference
0
Earnings History > 22 > surprise Percent
-
Earnings History > 23 > period
2019-08-31
Earnings History > 23 > report Date
2019-08-31
Earnings History > 23 > date
2019-08-31
Earnings History > 23 > before After Market
-
Earnings History > 23 > currency
CAD
Earnings History > 23 > eps Actual
-0.1423
Earnings History > 23 > eps Estimate
-
Earnings History > 23 > eps Difference
0
Earnings History > 23 > surprise Percent
-
Earnings History > 24 > period
2019-05-31
Earnings History > 24 > report Date
2019-05-31
Earnings History > 24 > date
2019-05-31
Earnings History > 24 > before After Market
-
Earnings History > 24 > currency
CAD
Earnings History > 24 > eps Actual
-0.1756
Earnings History > 24 > eps Estimate
-
Earnings History > 24 > eps Difference
0
Earnings History > 24 > surprise Percent
-
Earnings History > 25 > period
2019-02-28
Earnings History > 25 > report Date
2019-02-28
Earnings History > 25 > date
2019-02-28
Earnings History > 25 > before After Market
-
Earnings History > 25 > currency
CAD
Earnings History > 25 > eps Actual
-0.1494
Earnings History > 25 > eps Estimate
-
Earnings History > 25 > eps Difference
0
Earnings History > 25 > surprise Percent
-
Earnings History > 26 > period
2018-11-30
Earnings History > 26 > report Date
2018-11-30
Earnings History > 26 > date
2018-11-30
Earnings History > 26 > before After Market
-
Earnings History > 26 > currency
CAD
Earnings History > 26 > eps Actual
-0.213
Earnings History > 26 > eps Estimate
-
Earnings History > 26 > eps Difference
0
Earnings History > 26 > surprise Percent
-
Earnings History > 27 > period
2018-08-31
Earnings History > 27 > report Date
2018-08-31
Earnings History > 27 > date
2018-08-31
Earnings History > 27 > before After Market
-
Earnings History > 27 > currency
CAD
Earnings History > 27 > eps Actual
-0.2113
Earnings History > 27 > eps Estimate
-
Earnings History > 27 > eps Difference
0
Earnings History > 27 > surprise Percent
-
Earnings History > 28 > period
2018-05-31
Earnings History > 28 > report Date
2018-05-31
Earnings History > 28 > date
2018-05-31
Earnings History > 28 > before After Market
-
Earnings History > 28 > currency
CAD
Earnings History > 28 > eps Actual
-0.2244
Earnings History > 28 > eps Estimate
-
Earnings History > 28 > eps Difference
0
Earnings History > 28 > surprise Percent
-
Earnings History > 29 > period
2018-02-28
Earnings History > 29 > report Date
2018-02-28
Earnings History > 29 > date
2018-02-28
Earnings History > 29 > before After Market
-
Earnings History > 29 > currency
CAD
Earnings History > 29 > eps Actual
-0.0944
Earnings History > 29 > eps Estimate
-
Earnings History > 29 > eps Difference
0
Earnings History > 29 > surprise Percent
-
Earnings History > 30 > period
2017-11-30
Earnings History > 30 > report Date
2017-11-30
Earnings History > 30 > date
2017-11-30
Earnings History > 30 > before After Market
-
Earnings History > 30 > currency
CAD
Earnings History > 30 > eps Actual
-0.1178
Earnings History > 30 > eps Estimate
-
Earnings History > 30 > eps Difference
0
Earnings History > 30 > surprise Percent
-
Earnings History > 31 > period
2017-08-31
Earnings History > 31 > report Date
2017-08-31
Earnings History > 31 > date
2017-08-31
Earnings History > 31 > before After Market
-
Earnings History > 31 > currency
CAD
Earnings History > 31 > eps Actual
-0.1736
Earnings History > 31 > eps Estimate
-
Earnings History > 31 > eps Difference
0
Earnings History > 31 > surprise Percent
-
Earnings History > 32 > period
2017-05-31
Earnings History > 32 > report Date
2017-05-31
Earnings History > 32 > date
2017-05-31
Earnings History > 32 > before After Market
-
Earnings History > 32 > currency
CAD
Earnings History > 32 > eps Actual
-0.4281
Earnings History > 32 > eps Estimate
-
Earnings History > 32 > eps Difference
0
Earnings History > 32 > surprise Percent
-
Earnings History > 33 > period
2017-02-28
Earnings History > 33 > report Date
2017-02-28
Earnings History > 33 > date
2017-02-28
Earnings History > 33 > before After Market
-
Earnings History > 33 > currency
CAD
Earnings History > 33 > eps Actual
-0.1994
Earnings History > 33 > eps Estimate
-
Earnings History > 33 > eps Difference
0
Earnings History > 33 > surprise Percent
-
Earnings History > 34 > period
2016-11-30
Earnings History > 34 > report Date
2016-11-30
Earnings History > 34 > date
2016-11-30
Earnings History > 34 > before After Market
-
Earnings History > 34 > currency
CAD
Earnings History > 34 > eps Actual
-0.4491
Earnings History > 34 > eps Estimate
-
Earnings History > 34 > eps Difference
0
Earnings History > 34 > surprise Percent
-
Algernon Health Inc. operates as a clinical stage pharmaceutical development company in Canada and Australia. The company focuses on developing the therapeutic drugs in the areas of non-alcoholic steatohepatitis, liver disease, chronic kidney disease, and stroke program. Its pipeline includes repirinast for the treatment of chronic kidney disease; and N,N-Dimethyltryptamine for the treatment of strokes and traumatic brain injuries. The company was formerly known as Algernon Pharmaceuticals Inc. and changed its name to Algernon Health Inc. in October 2025. Algernon Health Inc. was incorporated in 2015 and is headquartered in Vancouver, Canada.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AAlgernon Pharmaceuticals Inc. (OTCMKTS:AGNPF) Short Interest Update Defense World
Read more →CDN $4M non-dilutive deal backs Algernon Health name change; plans four PET neuroimaging clinics Stock Titan
Read more →Showing 2 of 3
(Last Updated 2025-08-31)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Algernon Pharmaceuticals Inc
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-05-31
EPS Actual
-0.0143
EPS Estimate
—
EPS Difference
0
Surprise Percent
0%
(Last Updated 2025-08-31)
(Last Updated 2025-08-31)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-08-31)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-08-31)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.